Press releases

23
Sep 2013
20:30 E.S.T.

Cellectis bioresearch launches Compact TALEN™ the next generation of TAL effector nucleases

Read more
8
Jul 2013
20:30 E.S.T.

Scéil™: a new offering for the general public to turn adult cells into stem cells and store them

Read more
4
Jul 2013
20:30 E.S.T.

Cellectis Group announces groundbreaking in vivo proof of concept testing of their flagship UCART19 product for curative therapy of leukemia

Read more
26
Jun 2013
20:30 E.S.T.

Cellectis has successfully engineered the genome of photosynthetic algae with a view to biofuel production

Read more
18
Jun 2013
20:30 E.S.T.

Cellectis SA Combined General Shareholders’ Meeting of June 14, 2013

Read more
6
Jun 2013
20:30 E.S.T.

Cellectis plant sciences CEO Luc Mathis joins Board of Directors of the French Association for Plant Biotechnology (AFBV)

Read more
28
May 2013
20:30 E.S.T.

TAL-effector nuclease: The USPTO issues a third patent licensed to Cellectis

Read more
21
May 2013
20:30 E.S.T.

Compact TALEN™: the next generation of TAL effector nucleases – The Scientific journal Nature Communications publishes an innovative study on ultra precise Compact TALEN™ mini DNA cutters

Read more
16
May 2013
20:30 E.S.T.

TAL-effector nuclease: Issuance by the USPTO of Two New Patents – Cellectis provides its customers TALEN™ product under license of these patents to easily achieve any genome engineering projects.

Read more
2
May 2013
20:30 E.S.T.

David Sourdive, Vice President of Corporate Development at Cellectis, has been appointed by French Foreign Trade Minister Nicole Bricq to boost France’s export performance in the health sector

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US